Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Bracoud

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Alzheimer'S Disease : JAD|November 21, 2017
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical TrialGordon K Wilcock, Serge Gauthier, Giovanni B Frisoni, et al.
JAMA Neurology|September 29, 2015
Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical TrialVladimir Coric, Stephen Salloway, Christopher H van Dyck, et al.
CNS Drugs|December 1, 2025
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional TrialsSusan Abushakra, P Murali Doraiswamy, John A Hey, et al.
Stroke|March 1, 2014
Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASILChristian Opherk, Mariya Gonik, Marco Duering, et al.
BMJ Open|June 25, 2021
Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudyChinedu T Udeh-Momoh, Tamlyn Watermeyer, Geraint Price, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Alzheimer'S Disease : JAD|November 21, 2017
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical TrialGordon K Wilcock, Serge Gauthier, Giovanni B Frisoni, et al.
JAMA Neurology|September 29, 2015
Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical TrialVladimir Coric, Stephen Salloway, Christopher H van Dyck, et al.
CNS Drugs|December 1, 2025
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional TrialsSusan Abushakra, P Murali Doraiswamy, John A Hey, et al.
Stroke|March 1, 2014
Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASILChristian Opherk, Mariya Gonik, Marco Duering, et al.
BMJ Open|June 25, 2021
Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudyChinedu T Udeh-Momoh, Tamlyn Watermeyer, Geraint Price, et al.
Pageof 3